These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9367867

  • 1. The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation.
    Gana-Weisz M, Haklai R, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):900-4. PubMed ID: 9367867
    [Abstract] [Full Text] [Related]

  • 2. Dislodgment and accelerated degradation of Ras.
    Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y.
    Biochemistry; 1998 Feb 03; 37(5):1306-14. PubMed ID: 9477957
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y, Weisz B, Gana-Weisz M, Ben-Baruch G, Kloog Y.
    Int J Cancer; 1999 Mar 15; 80(6):911-8. PubMed ID: 10074926
    [Abstract] [Full Text] [Related]

  • 4. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 15; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 5. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y.
    Clin Cancer Res; 2002 Feb 15; 8(2):555-65. PubMed ID: 11839677
    [Abstract] [Full Text] [Related]

  • 6. Stringent structural requirements for anti-Ras activity of S-prenyl analogues.
    Aharonson Z, Gana-Weisz M, Varsano T, Haklai R, Marciano D, Kloog Y.
    Biochim Biophys Acta; 1998 Feb 27; 1406(1):40-50. PubMed ID: 9545527
    [Abstract] [Full Text] [Related]

  • 7. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid.
    Marom M, Haklai R, Ben-Baruch G, Marciano D, Egozi Y, Kloog Y.
    J Biol Chem; 1995 Sep 22; 270(38):22263-70. PubMed ID: 7673206
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S, Weis B, Aeed H, Gana-Weis M, Zaidel L, Avni Y, Romanelli RG, Pinzani M, Kloog Y, Bruck R.
    J Hepatol; 1999 Dec 22; 31(6):1053-61. PubMed ID: 10604579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel Ras antagonist blocks human melanoma growth.
    Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer BX, Eichler H, Pehamberger H, Gana-Weisz M, Ben-David E, Kloog Y, Wolff K.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14019-24. PubMed ID: 10570191
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE, Pfeiffer JR, Lee RJ, Kusewitt DF, Martinez AM, Foutz T, Wilson BS, Oliver JM.
    J Immunol; 1998 Dec 15; 161(12):6733-44. PubMed ID: 9862703
    [Abstract] [Full Text] [Related]

  • 16. Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth.
    Marciano D, Ben-Baruch G, Marom M, Egozi Y, Haklai R, Kloog Y.
    J Med Chem; 1995 Apr 14; 38(8):1267-72. PubMed ID: 7731012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
    Zhao Y, Fan D, Ru B, Cheng KW, Hu S, Zhang J, Li ET, Wang M.
    Eur J Cancer; 2016 Nov 15; 68():38-50. PubMed ID: 27710830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.